Physician Wealth Advisors’s Franco-Nevada FNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
482
+2
+0.4% +$466 0.01% 313
2026
Q1
$119K Hold
480
0.02% 255
2025
Q4
$99.5K Sell
480
-15
-3% -$3.04K 0.01% 278
2025
Q3
$110K Sell
495
-18
-4% -$3.24K 0.02% 263
2025
Q2
$84.1K Buy
513
+95
+23% +$15.7K 0.01% 285
2025
Q1
$65.9K Hold
418
0.01% 297
2024
Q4
$49.2K Buy
+418
New +$51.7K 0.01% 346

Other funds holding FNV

Physician Wealth Advisors's FNV Position: Q2 2026 in Review

Physician Wealth Advisors increased its Franco-Nevada (FNV) stake by 0.42% in Q2 2026, buying an estimated $466 and bringing the position to 482 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #313.

Physician Wealth Advisors first reported a position in FNV in Q4 2024 and has held it in 7 quarters since. The position peaked at $119K in Q1 2026. 222 funds tracked by Wall St. Rank hold FNV as of Q2 2026.

  • Physician Wealth Advisors held 482 shares of Franco-Nevada worth $100K as of Q2 2026.
  • Physician Wealth Advisors bought 2 Franco-Nevada shares in Q2 2026, an estimated $466.
  • Franco-Nevada made up 0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #313 holding.
  • Physician Wealth Advisors first reported a position in Franco-Nevada in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Franco-Nevada position peaked at $119K in Q1 2026.
  • 222 funds tracked by Wall St. Rank held Franco-Nevada as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.